Genenta Science SPA (FRA:K5F) 5-Year EBITDA Growth Rate: -1.60% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:K5F Genenta Science SPA FRA:K5F
37 GF Score
Price €0.68
! 4 Warning Signs
View Full Analysis

What is Genenta Science SPA 5-Year EBITDA Growth Rate?

Genenta Science SPA FRA:K5F -6.90% 37 5-Year EBITDA Growth Rate is -1.60% as of Dec. 2025. GuruFocus rates FRA:K5F with a GF Score™ of 37/100. The stock has 4 warning signs investors should review.

Genenta Science SPA's EBITDA per Share for the six months ended in Dec. 2025 was €-0.16.

During the past 3 years, the average EBITDA Per Share Growth Rate was 18.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Genenta Science SPA was 18.00% per year. The lowest was -24.90% per year. And the median was -16.25% per year.

Genenta Science SPA  (FRA:K5F) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Genenta Science SPA 5-Year EBITDA Growth Rate Related Terms

FRA:K5F vs VRTX, REGN, MRNA: 5-Year EBITDA Growth Rate Comparison

For the Conglomerates subindustry, Genenta Science SPA's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genenta Science SPA 5-Year EBITDA Growth Rate vs Conglomerates Industry

For the Conglomerates industry and Industrials sector, Genenta Science SPA's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Genenta Science SPA's 5-Year EBITDA Growth Rate falls into.


FRA:K5F
37GF Score
Genenta Science SPA FRA:K5F
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genenta Science SPA 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of -1.60% mean?
Genenta Science SPA (FRA:K5F) has a 5-Year EBITDA Growth Rate of -1.60% as of Dec. 2025. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Genenta Science SPA and its competitors.
Is Genenta Science SPA's 5-Year EBITDA Growth Rate too high?
Genenta Science SPA's current 5-Year EBITDA Growth Rate is -1.60%. Overall, Genenta Science SPA has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Genenta Science SPA's 5-Year EBITDA Growth Rate compare to VRTX and REGN?
Genenta Science SPA's 5-Year EBITDA Growth Rate of -1.60% can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Conglomerates company?
A good 5-Year EBITDA Growth Rate depends on the Conglomerates industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Genenta Science SPA and its competitors. Genenta Science SPA's current 5-Year EBITDA Growth Rate is -1.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genenta Science SPA stock overvalued right now?
Genenta Science SPA (FRA:K5F) has a current 5-Year EBITDA Growth Rate of -1.60%. The current 5-Year EBITDA Growth Rate is -1.60%. Genenta Science SPA's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Genenta Science SPA (FRA:K5F), the current 5-Year EBITDA Growth Rate is -1.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genenta Science SPA Business Description

Other Exchanges GNTA:USA
Address Via dell’Annunciata No. 31, Milan, ITA, 20121
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
37GF Score

Get the complete analysis for FRA:K5F

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.68
Price